FENNEC PHARMACEUTICALS INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jun 1996 | — | $0 | — |
| Sep 1996 | — | $0 | $0 |
| Jun 1997 | — | $-37.0K | — |
| Jun 1997 | — | $-37.0K | — |
| Jun 1998 | — | $-435.0K | — |
| Jun 1999 | — | $242.0K | — |
| Jun 2000 | — | $47.0K | — |
| Jun 2001 | — | $9.8M | — |
| Jun 2002 | — | $6.1M | — |
| Jun 2003 | — | $698.0K | — |
| Jun 2004 | — | $20.5M | — |
| Dec 2004 | — | $16.7M | — |
| Dec 2005 | — | $11.1M | — |
| Dec 2006 | — | $1.3M | — |
| Dec 2007 | — | $14.1M | — |
| Dec 2008 | — | $3.1M | — |
| Dec 2009 | — | $406.0K | $685.0K |
| Mar 2010 | — | — | $348.0K |
| Jun 2010 | — | — | $7.2M |
| Sep 2010 | — | — | $6.6M |
| Dec 2010 | — | $-4.9M | $5.9M |
| Mar 2011 | — | $-283.0K | $5.0M |
| Jun 2011 | — | $-684.0K | $6.8M |
| Sep 2011 | — | $-3.7M | $6.2M |
| Dec 2011 | — | $-120.0K | $5.3M |
| Mar 2012 | — | $2.6M | $4.7M |
| Jun 2012 | — | $2.0M | $3.6M |
| Sep 2012 | — | $1.3M | $2.9M |
| Dec 2012 | — | $-5.0M | $2.3M |
| Mar 2013 | — | $-9.1M | $1.9M |
| Jun 2013 | — | $-2.4M | $1.0M |
| Sep 2013 | — | $-4.1M | $538.0K |
| Dec 2013 | — | $-1.5M | $1.7M |
| Mar 2014 | — | $-4.3M | $1.3M |
| Jun 2014 | — | $-4.7M | $1.0M |
| Sep 2014 | — | $-3.2M | $593.0K |
| Dec 2014 | — | $613.0K | $2.3M |
| Mar 2015 | — | $826.0K | $1.9M |
| Jun 2015 | — | $1.1M | $1.9M |
| Sep 2015 | — | $1.0M | $1.4M |
| Dec 2015 | — | $548.0K | $942.0K |
| Mar 2016 | — | $243.0K | $545.0K |
| Jun 2016 | — | $4.7M | $5.1M |
| Sep 2016 | — | $4.2M | $4.5M |
| Dec 2016 | — | $3.6M | $3.9M |
| Mar 2017 | — | $2.9M | $3.3M |
| Jun 2017 | — | $9.7M | $10.2M |
| Sep 2017 | — | $8.9M | $9.7M |
| Dec 2017 | — | $26.8M | $28.3M |
| Mar 2018 | — | $25.7M | $26.7M |
| Jun 2018 | — | $24.9M | $25.6M |
| Sep 2018 | — | $22.9M | $24.5M |
| Dec 2018 | — | $21.3M | $22.8M |
| Mar 2019 | — | $19.2M | $20.2M |
| Jun 2019 | — | $16.5M | $13.7M |
| Sep 2019 | — | $15.0M | $15.2M |
| Dec 2019 | — | $11.9M | $13.7M |
| Mar 2020 | — | $8.5M | $9.9M |
| Jun 2020 | — | $36.1M | $38.7M |
| Sep 2020 | — | $31.2M | $33.2M |
| Dec 2020 | — | $29.1M | $30.3M |
| Mar 2021 | — | $24.9M | $26.8M |
| Jun 2021 | — | $22.3M | $27.3M |
| Sep 2021 | — | $19.0M | $24.3M |
| Dec 2021 | $5.0M | $15.8M | $21.1M |
| Mar 2022 | $4.5M | $12.5M | $18.3M |
| Jun 2022 | $4.0M | $8.5M | $14.9M |
| Sep 2022 | $25.0M | $2.8M | $29.8M |
| Dec 2022 | $24.9M | $-2.6M | $23.8M |
| Mar 2023 | $25.1M | $-7.3M | $18.4M |
| Jun 2023 | $25.4M | $-9.7M | $15.0M |
| Sep 2023 | $25.6M | $-10.5M | $12.4M |
| Dec 2023 | $30.9M | $-11.6M | $13.3M |
| Mar 2024 | $31.3M | $3.0M | $51.2M |
| Jun 2024 | $31.8M | $-1.4M | $43.1M |
| Sep 2024 | $32.1M | $-5.2M | $40.3M |
| Dec 2024 | $19.3M | $-5.9M | $26.6M |
| Mar 2025 | $19.4M | $-5.9M | $22.7M |
| Jun 2025 | $19.4M | $-7.5M | $18.7M |
| Sep 2025 | $19.4M | $-4.5M | $21.9M |
| Dec 2025 | — | $35.5M | $36.8M |
| Mar 2026 | — | $37.7M | $40.2M |
| Jun 2026 | — | $42.4M | $41.2M |